Clearmind Medicine Inc.
CMND· Nasdaq
Source filing unavailable
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures |
|---|---|---|
| Net Income | -$687.84K | -$884.74K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Clearmind Medicine Inc. · CIK 1892500 · Engraved from SEC EDGAR